SKA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.466200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.198600E-01
Normal-vs-Stage2
9.997800E-01
Normal-vs-Stage3
3.297800E-01
Normal-vs-Stage4
5.721200E-01
Stage1-vs-Stage2
7.395800E-01
Stage1-vs-Stage3
4.708800E-01
Stage1-vs-Stage4
9.041400E-01
Stage2-vs-Stage3
2.497000E-01
Stage2-vs-Stage4
6.875200E-01
Stage3-vs-Stage4
4.618400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.486000E-01
Normal-vs-AfricanAmerican
9.571000E-01
Normal-vs-Asian
9.388000E-01
Caucasian-vs-AfricanAmerican
9.762000E-01
Caucasian-vs-Asian
8.038200E-01
AfricanAmerican-vs-Asian
8.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.519200E-01
Normal-vs-Female
9.272200E-01
Male-vs-Female
9.957800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.925000E-01
Normal-vs-Age(41-60Yrs)
5.027600E-01
Normal-vs-Age(61-80Yrs)
7.718200E-01
Normal-vs-Age(81-100Yrs)
7.409800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.905600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.154600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.490600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.596400E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.159800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.336400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.219400E-01
Normal-vs-Daily Drinker
8.806000E-01
Normal-vs-Weekly Drinker
9.298800E-01
Normal-vs-Occasional Drinker
6.690200E-01
Normal-vs-Social Drinker
7.562400E-01
Non Drinker-vs-Daily Drinker
2.303400E-01
Non Drinker-vs-Weekly Drinker
2.298000E-01
Non Drinker-vs-Occasional Drinker
7.004400E-02
Non Drinker-vs-Social Drinker
4.703800E-02
Daily Drinker-vs-Weekly Drinker
6.802800E-01
Daily Drinker-vs-Occasional Drinker
2.551000E-01
Daily Drinker-vs-Social Drinker
3.932000E-01
Weekly Drinker-vs-Occasional Drinker
4.940200E-01
Weekly Drinker-vs-Social Drinker
7.466000E-01
Occasional Drinker-vs-Social Drinker
6.493800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.825600E-01
Normal-vs-Grade 2
8.677800E-01
Normal-vs-Grade 3
9.057800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.546800E-01
Grade 1-vs-Grade 3
6.680400E-01
Grade 1-vs-Grade 4
8.825600E-01
Grade 2-vs-Grade 3
3.044600E-01
Grade 2-vs-Grade 4
8.677800E-01
Grade 3-vs-Grade 4
9.057800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.237600E-01
Normal-vs-NonDiabetic
8.602400E-01
Diabetic-vs-NonDiabetic
1.213210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.346200E-01
Normal-vs-NoPancreatitis
9.431200E-01
Pancreatitis-vs-NoPancreatitis
7.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.799600E-01
Normal-vs-N1
9.822200E-01
N0-vs-N1
2.539800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.172800E-01
Normal-vs-TP53-NonMutant
8.046000E-01
TP53-Mutant-vs-TP53-NonMutant
2.781200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
